Cargando…

Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland

BACKGROUND: Cholangiocarcinoma (CCA) is a cancer arising from the intra‐ and extrahepatic bile ducts. The early stages are often asymptomatic, CCA is frequently diagnosed in an advanced stage and the prognosis of CCA is often dismal. OBJECTIVE: Our objective was to estimate the incidence of CCA in F...

Descripción completa

Detalles Bibliográficos
Autores principales: Barner‐Rasmussen, Nina, Pukkala, Eero, Hadkhale, Kishor, Färkkilä, Martti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672081/
https://www.ncbi.nlm.nih.gov/pubmed/34533900
http://dx.doi.org/10.1002/ueg2.12154
_version_ 1784615285458731008
author Barner‐Rasmussen, Nina
Pukkala, Eero
Hadkhale, Kishor
Färkkilä, Martti
author_facet Barner‐Rasmussen, Nina
Pukkala, Eero
Hadkhale, Kishor
Färkkilä, Martti
author_sort Barner‐Rasmussen, Nina
collection PubMed
description BACKGROUND: Cholangiocarcinoma (CCA) is a cancer arising from the intra‐ and extrahepatic bile ducts. The early stages are often asymptomatic, CCA is frequently diagnosed in an advanced stage and the prognosis of CCA is often dismal. OBJECTIVE: Our objective was to estimate the incidence of CCA in Finland and to identify risk factors for CCA, with a special interest in primary sclerosing cholangitis (PSC). METHODS: We identified all CCA cases during 1974–2018 from the Finnish Cancer Registry and calculated age‐standardised incidence rates. Five controls for each case were extracted from the Population Registry, matched by age, gender and municipality of residence at the time of diagnosis. Odds ratios (ORs) for risk factors were estimated with conditional logistic regression and survival estimates with the Kaplan–Meier method. RESULTS: Incidence of CCA remained stable in both genders; the age‐standardised rate (World Standard) in 2013–2017 in males and females was 1.7 per 100,000 person years and 1.3 per 100,000 person years, respectively. Primary sclerosing cholangitis carried a 30‐fold risk of intrahepatic cholangiocarcinoma (iCCA) and 25‐fold risk of extrahepatic cholangiocarcinoma (eCCA). Diabetes, inflammatory bowel disease and liver cirrhosis were associated with iCCA, whereas cholelithiasis and viral hepatitis C were associated with eCCA. The cumulative 5‐year survival was 4.6%. CONCLUSIONS: The incidence of CCA has been stable. Known risk factors for CCA were confirmed, with PSC having the highest OR. Survival remains poor.
format Online
Article
Text
id pubmed-8672081
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86720812021-12-21 Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland Barner‐Rasmussen, Nina Pukkala, Eero Hadkhale, Kishor Färkkilä, Martti United European Gastroenterol J Hepatobiliary BACKGROUND: Cholangiocarcinoma (CCA) is a cancer arising from the intra‐ and extrahepatic bile ducts. The early stages are often asymptomatic, CCA is frequently diagnosed in an advanced stage and the prognosis of CCA is often dismal. OBJECTIVE: Our objective was to estimate the incidence of CCA in Finland and to identify risk factors for CCA, with a special interest in primary sclerosing cholangitis (PSC). METHODS: We identified all CCA cases during 1974–2018 from the Finnish Cancer Registry and calculated age‐standardised incidence rates. Five controls for each case were extracted from the Population Registry, matched by age, gender and municipality of residence at the time of diagnosis. Odds ratios (ORs) for risk factors were estimated with conditional logistic regression and survival estimates with the Kaplan–Meier method. RESULTS: Incidence of CCA remained stable in both genders; the age‐standardised rate (World Standard) in 2013–2017 in males and females was 1.7 per 100,000 person years and 1.3 per 100,000 person years, respectively. Primary sclerosing cholangitis carried a 30‐fold risk of intrahepatic cholangiocarcinoma (iCCA) and 25‐fold risk of extrahepatic cholangiocarcinoma (eCCA). Diabetes, inflammatory bowel disease and liver cirrhosis were associated with iCCA, whereas cholelithiasis and viral hepatitis C were associated with eCCA. The cumulative 5‐year survival was 4.6%. CONCLUSIONS: The incidence of CCA has been stable. Known risk factors for CCA were confirmed, with PSC having the highest OR. Survival remains poor. John Wiley and Sons Inc. 2021-09-17 /pmc/articles/PMC8672081/ /pubmed/34533900 http://dx.doi.org/10.1002/ueg2.12154 Text en © 2021 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Hepatobiliary
Barner‐Rasmussen, Nina
Pukkala, Eero
Hadkhale, Kishor
Färkkilä, Martti
Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
title Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
title_full Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
title_fullStr Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
title_full_unstemmed Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
title_short Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland
title_sort risk factors, epidemiology and prognosis of cholangiocarcinoma in finland
topic Hepatobiliary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8672081/
https://www.ncbi.nlm.nih.gov/pubmed/34533900
http://dx.doi.org/10.1002/ueg2.12154
work_keys_str_mv AT barnerrasmussennina riskfactorsepidemiologyandprognosisofcholangiocarcinomainfinland
AT pukkalaeero riskfactorsepidemiologyandprognosisofcholangiocarcinomainfinland
AT hadkhalekishor riskfactorsepidemiologyandprognosisofcholangiocarcinomainfinland
AT farkkilamartti riskfactorsepidemiologyandprognosisofcholangiocarcinomainfinland